(Q51657792)

9 April 2018

title

Sympathetic nervous system activity during sodium restriction in essential hypertension. (English)

1 reference

9 April 2018

main subject

arterial hypertension

0 references

author name string

Warren SE

series ordinal

1

1 reference

9 April 2018

Vieweg WV

series ordinal

2

1 reference

9 April 2018

O'Connor DT

series ordinal

3

1 reference

9 April 2018

publication date

1 October 1980

1 reference

9 April 2018

published in

Clinical Cardiology

1 reference

9 April 2018

volume

3

1 reference

9 April 2018

page(s)

348-351

1 reference

9 April 2018

issue

5

1 reference

9 April 2018

Circulating catecholamine levels in human and experimental hypertension

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

Salt, volume and the prevention of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

Plasma Levels of Norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

Effect of acute volume alterations on norepinephrine and dopamine-beta-hydroxylase in normotensive and hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

Plasma and urinary norepinephrine values at extremes of sodium intake in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

Changes in plasma norepinephrine, blood pressure and heart rate during physical activity in hypertensive man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

Coronary heart-disease after treatment of hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

Salt and hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

The distribution of intrarenal blood flow in normal and hypertensive man

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

High sodium-low potassium environment and hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

Plasma norepinephrine variations with dietary sodium intake

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

Effect of Weight Loss without Salt Restriction on the Reduction of Blood Pressure in Overweight Hypertensive Patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

Effect of Sodium Intake on Plasma Catecholamines in Normal Subjects*

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

Decreased venous distensibility in borderline hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

Noradrenaline release from isolated nerve granules

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

Plasma noradrenaline increases with age

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960030410

7 January 2021

Identifiers

DOI

10.1002/CLC.4960030410

1 reference

9 April 2018

PubMed ID

7002404

1 reference

9 April 2018